Insider Purchases: Inside the Buy

Tag: Growth vs Value

Illustration of a worn sneaker representing Nike stock decline transitioning into a glowing running shoe symbolizing a potential turnaround, with a rising stock chart and investors buying at the bottom.

April 9, 2026

Nike (NKE) Stock: Insiders Keep Buying the Dip—Should You? 👟

Nike (NKE) has fallen sharply from its highs, but insider buying, strong brand equity, and improved valuation are turning heads. Is this the start of a comeback—or a trap?

Read entire article

Tags: buy or sell NKE, CEO Buy, consumer brands, dividend stocks, DividendGrowth, Elliott Hill, featured-insiders, FUNanc1al, FunStock, growth vs value, hub-insiders, insider buying, InsiderBuying, Nike stock, NikeStock, NKE, NKE analysis, retail stocks, risks buying NKE, share repurchase program, stock market 2026, StockMarket2026, TimCook, turnaround stocks, value investing, ValueInvesting, why buy NKE

June 20, 2025

Oscar Health: Its Own Is Shining and Insiders Knew!

Co-founder Joshua Kushner and Thrive Partners bought over $23 million of Oscar Health stock in late 2024. Since then? Record earnings, soaring revenue, and a stock still (surprisingly) within range. A healthy bet — or just a well-insured hunch?

Read entire article

Tags: Funanc1al, Funanc1al Edge, Funanc1al for Investors, Funanc1al Insider Series, Funanc1al Investing, Funanc1alEdge, Funanc1alInsiderSeries, Funanc1alInvesting, Funanc1alStocks, Growth vs Value, GrowthStocks, HealthcareStocks, insider buying, Insider Buys, Insider Purchases, insider trading, InsiderActivity, InsiderBuys, InsiderPurchases, InsiderScoops, Kushner, OscarHealth, OSCR, OSCR Stock, SmartMoney

Your cart

Insider Purchases: Inside the Buy

Tag: Growth vs Value

April 9, 2026

Nike (NKE) Stock: Insiders Keep Buying the Dip—Should You? 👟

June 20, 2025

Oscar Health: Its Own Is Shining and Insiders Knew!

Quick links

Contact us

About us

Follow us